Holly Barker 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• Ovarian carcinosarcoma genomics and preclinical models enable identification novel mechanisms of action of eribulin on N-MYC and the mevalonate pathway — Session 1: Cancers of the Reproductive Organs 1